A study investigating the effect of pomalidomide in real world United Kingdom patients with relapsed or refractory myeloma

Trial Profile

A study investigating the effect of pomalidomide in real world United Kingdom patients with relapsed or refractory myeloma

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Aug 2015

At a glance

  • Drugs Pomalidomide (Primary) ; Dexamethasone
  • Indications Myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Aug 2015 New trial record
    • 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top